Skip to main content Skip to main navigation menu Skip to site footer

Overview of transfusion reactions in patients with incompatible crossmatch at Sanglah General Hospital, Denpasar, Bali, Indonesia


Background: Transfusion reaction is a side effect of giving complete blood or one of the components. They vary in severity, ranging from reactions that can occur during a transfusion (acute transfusion reactions) or reactions occurring days to weeks later (delayed transfusion reactions) and can be immunological and non-immunological. This study investigated the description of transfusion reactions in patients who received blood with incompatible crossmatch results at Sanglah General Hospital

Methods: This research is a descriptive study with a cross-sectional approach. Several parameters were assessed in this study to determine the transfusion reaction in patients who receive blood with incompatible crossmatch. Data were analyzed using SPSS version 20 for Windows.

Results: In this study, from 72 patients who received incompatible blood, 75.0% were found for women and 25.0% for male patients, most of whom were aged 41-65 years (65.0%). Most blood type is blood type O (52.0%). In this study, 6 patients (8.3%) got transfusion reactions such as fever accompanied by chills, urticaria, hypotension, and shortness of breath.

Conclusions: Incompatible crossmatch blood administration can be given. If a reaction is given to a crossmatch transfusion that is not suitable, symptomatic therapy can be given because the response provided is only acute and mild.


  1. Kehl A, Truchet L, Langbein-Detsch I, Müller E, Giger U. Updates on practical ABC blood compatibility testing in cats. Neuigkeiten zur praktischen ABC-Blutgruppen-Bestimmung bei Katzen. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2019;47(6):425-438.
  2. Arslan O. Electronic crossmatching. Transfus Med Rev. 2006;20(1):75-79.
  3. Babiker HA, Elsayed TY. Frequency of alloantibodies among chronic renal failure patients in red sea state. Indian J Hematol Blood Transfus. 2014;30(3):187-190.
  4. Fridey JL, Townsend MJ, Kessler DA, Gregory KR. A question of clarity: redesigning the American Association Of Blood Banks blood donor history questionnaire--a chronology and model for donor screening. Transfus Med Rev. 2007;21(3):181-204.
  5. Lestari AAW, Mulyantari NK, Prabawa IPY. The role of Stromal Cell-Derived Factor 1 (SDF-1) and Transforming Growth-Factor-Beta 1 (TGF-β1) levels in Packed Red Cells (PRC) as the indicator of storage lesion at Sanglah Hospital-Blood Bank, Bali, Indonesia. Indonesia Journal of Biomedical Science. 2022;16(1):9-13.
  6. Savage WJ. Transfusion Reactions. Hematol Oncol Clin North Am. 2016;30(3):619-634.
  7. Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, et al. Transfusion reactions: prevention, diagnosis, and treatment. Lancet. 2016;388(10061):2825-2836.
  8. Ness PM. Transfusion medicine: an overview and update. Clin Chem. 2000;46(8 Pt 2):1270-1276.
  9. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085-98.
  10. Szczepiorkowski ZM, Dunbar NM. Transfusion guidelines: when to transfuse. Hematology Am Soc Hematol Educ Program. 2013;2013:638-644.
  11. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016;316(19):2025-2035.
  12. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;157(1):49-58.
  13. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?. Blood. 2001;97(5):1180-1195.
  14. Mulyantari NK, Prabawa IPY. Analysis of Soluble Cluster of Differentiation 40 Ligand (SD40L) levels between thrombocyte apheresis and thrombocyte whole blood products in Sanglah General Hospital blood bank. Bali Med J. 2019; 8(1):173-78.
  15. Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol. 2012;159(2):143-53.
  16. Fujii Y, Shibata Y, Miyata S, Inaba S, Asai T, Hoshi Y, et al. Consecutive national surveys of ABO-incompatible blood transfusion in Japan. Vox Sang. 2009;97(3):240-6.
  17. Yousuf R, Abdul Aziz S, Yusof N, Leong CF. Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre. Indian J Hematol Blood Transfus. 2013;29(2):65-70.
  18. Zimring JC, Spitalnik SL. Pathobiology of transfusion reactions. Annu Rev Pathol. 2015;10:83-110.

How to Cite

Betti Bettavia Hartama Pardosi, Ni Kadek Mulyantari, Ida Ayu Putri Wirawati, Anak Agung Wiradewi Lestari, & Ni Nyoman Mahartini. (2022). Overview of transfusion reactions in patients with incompatible crossmatch at Sanglah General Hospital, Denpasar, Bali, Indonesia. Bali Medical Journal, 11(2), 506–509.




Search Panel

Betti Bettavia Hartama Pardosi
Google Scholar
BMJ Journal

Ni Kadek Mulyantari
Google Scholar
BMJ Journal

Ida Ayu Putri Wirawati
Google Scholar
BMJ Journal

Anak Agung Wiradewi Lestari
Google Scholar
BMJ Journal

Ni Nyoman Mahartini
Google Scholar
BMJ Journal